Summary: Scientists have developed a potential vaccine for Tasmanian devils against transmissible cancers, called devil facial tumours (DFTs), that affect thousands of animals each year. The vaccine uses an attenuated adenovirus to make DFT cells more visible to the devil’s immune system, and key immune targets have been identified in the tumour cells. An oral bait delivery system for the vaccine is also being developed, to avoid the need to capture and inject every devil. Successful deployment of the vaccine could help re-establish a healthy wild devil population. The researchers have received a grant to develop better baits and ways to monitor wildlife health in the field. Full story

Leave a Reply

Your email address will not be published. Required fields are marked *